Brief: Daré Bioscience Announces Initiation Of Subject Enrollment In A Phase 1 Thermography Study To Support Pharmacodynamic And Pharmacokinetic Characterization Of Sildenafil Cream, 3.6%

Dare Bioscience

20/04/2023 13:03

April 20 (Reuters) - Dare Bioscience Inc  DARE.O :
    * DARÉ BIOSCIENCE ANNOUNCES INITIATION OF SUBJECT ENROLLMENT
IN A
PHASE 1 THERMOGRAPHY STUDY TO SUPPORT PHARMACODYNAMIC AND
PHARMACOKINETIC CHARACTERIZATION OF SILDENAFIL CREAM, 3.6%
    * DARE BIOSCIENCE INC - TOPLINE DATA FOR EXPLORATORY PHASE
2B
RESPOND STUDY ANTICIPATED IN 2Q-2023

Source text for Eikon:  ID:nGNX5XDRCB 
Further company coverage:  DARE.O